Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | CES2 | O00748 | 1/20 | 0.32 |
| ▸ | CES1 | P23141 | 1/20 | 0.32 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.30 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.30 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.30 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.30 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL73471 | 0.84 | — | — | |
| SCHEMBL12468762 | 0.83 | HSD17B10 (0.30) | HSD17B10TDP1 | |
| SCHEMBL28131037 | 0.81 | HSD17B10 (0.41) | HSD17B10TDP1CES2CES1FFAR3 | |
| SCHEMBL1896137 | 0.81 | — | — | |
| SCHEMBL20819 | 0.81 | — | — | |
| SCHEMBL26065539 | 0.79 | CES2 (0.42) | HSD17B10TDP1CES2CES1 | |
| SCHEMBL9070600 | 0.79 | — | — | |
| Water SCHEMBL28130669 | 0.78 | — | — | |
| SCHEMBL28119866 | 0.78 | — | — | |
| SCHEMBL27265863 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2098501-B1 | METHOD FOR PRODUCING OPTICALLY ACTIVE FLUORINE-CONTAINING CARBONYL-ENE PRODUCT | CENTRAL GLASS CO LTD (JP) | 2017-08-23 | — | — | EP | disclosed |
| EP-2572783-B1 | Method of separating pentene-2 from a C5 cut containing pentene-2 and pentene-1 by selective oligomerisation of the pentene-1 | IFP Energies Nouvelles (FR) | 2014-11-12 | — | — | EP | disclosed |
| EP-2572783-A1 | Method of separating pentene-2 from a C5 cut containing pentene-2 and pentene-1 by selective oligomerisation of the pentene-1 | IFP Energies Nouvelles (FR) | 2013-03-27 | — | — | EP | disclosed |
| US-20130072733-A1 | METHOD OF SEPARATING PENTENE-2 FROM A C5 CUT CONTAINING PENTENE-2 AND PENTENE-1 BY SELECTIVE OLIGOMERIZATION OF PENTENE-1 | IFP Energies Nouvelles (FR) | 2013-03-21 | — | — | US | disclosed |
| EP-2035345-A2 | ANTI-CAKING AGENT | Construction Research and Technology GmbH (DE) | 2009-03-18 | — | — | EP | disclosed |
| WO-2008000326-A2 | ANTI-CAKING AGENT | CONSTRUCTION RESEARCH & TECHNOLOGY GMBH (DE) | 2008-01-03 | — | — | WO | disclosed |
| EP-0631588-A1 | HYDROCARBON RESINS, PROCESSES FOR THEIR MANUFACTURE AND ADHESIVE COMPOSITIONS CONTAINING SUCH RESINS. | EXXON CHEMICAL PATENTS INC (US) | 1995-01-04 | — | — | EP | disclosed |
| WO-1993019097-A2 | HYDROCARBON RESINS, PROCESSES FOR THEIR MANUFACTURE AND ADHESIVE COMPOSITIONS CONTAINING SUCH RESINS | EXXON CHEMICAL PATENTS INC. (US) | 1993-09-30 | — | — | WO | disclosed |
| EP-0174509-A2 | A dispersing agent for coal-water slurry | KURARAY CO., LTD. (JP) | 1986-03-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130072733-A1 | METHOD OF SEPARATING PENTENE-2 FROM A C5 CUT CONTAINING PENTENE-2 AND PENTENE-1 BY SELECTIVE OLIGOMERIZATION OF PENTENE-1 | C5, C9, OXER1 | HSD17B10 281/4885TDP1 2068/4885CES2 1380/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.